BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2019 3:03:24 AM | Browse: 875 | Download: 1154
 |
Received |
|
2019-02-28 02:02 |
|
Peer-Review Started |
|
2019-03-04 10:47 |
|
To Make the First Decision |
|
2019-06-05 06:26 |
|
Return for Revision |
|
2019-06-27 01:06 |
|
Revised |
|
2019-07-31 11:14 |
|
Second Decision |
|
2019-08-07 00:46 |
|
Accepted by Journal Editor-in-Chief |
|
2019-08-07 23:55 |
|
Accepted by Executive Editor-in-Chief |
|
2019-08-27 23:22 |
|
Articles in Press |
|
2019-08-27 23:22 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-09-03 19:05 |
|
Typeset the Manuscript |
|
2019-09-17 10:23 |
|
Publish the Manuscript Online |
|
2019-09-25 03:03 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Review |
| Article Title |
Suitability and limitations of mesenchymal stem cells to elucidate human bone illness
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Izaskun Mitxitorena, Arantza Infante, Blanca Gener and Clara I Rodríguez |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| ISCIII |
PI15/00820 |
| ISCIII |
PI18/00202 |
| Basque Country government |
kk-2018/00031/BC |
| Fundación Mutua Madrileña |
AP165892017 |
|
| Corresponding Author |
Clara I Rodríguez, PhD, Senior Scientist, Stem Cells and Cell Therapy Laboratory, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, Plaza de Cruces S/N, Barakaldo 48903, Bizkaia, Spain. cirodriguez@osakidetza.eus |
| Key Words |
Mesenchymal stem cells; Bone illness; Osteoporosis; Osteogenesis; Osteoanabolic therapies; In vitro cell models |
| Core Tip |
Human mesenchymal stem cells (hMSCs) have emerged as a encouraging therapeutic strategy for the treatment of bone diseases. Moreover, certain limitations of animal models for the study of bone disorders highlight the suitability and benefits of hMSCs for the elucidation of these pathologies. The current review explains the available strategies based on hMSCs for bone illness new treatments development and future directions in the field for a more accurate knowledge of the cause underlying these human pathologies. |
| Publish Date |
2019-09-25 03:03 |
| Citation |
Mitxitorena I, Infante A, Gener B, Rodríguez CI. Suitability and limitations of mesenchymal stem cells to elucidate human bone illness. World J Stem Cells 2019; 11(9):578-593 |
| URL |
https://www.wjgnet.com/1948-0210/full/v11/i9/578.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v11.i9.578 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
